Related Experiment Video
Updated: Jul 19, 2026

Murine Model of CD40-activation of B cells
Published on: March 5, 2010
Potential role of CARMA1 in CD40-induced splenic B cell proliferation and marginal zone B cell maturation
1Department of Molecular and Cellular Oncology, The University of Texas, MD Anderson Cancer Center, Houston, TX 77030, USA.
Insights
CARMA1 deficiency impairs B cell proliferation by disrupting cell-cycle progression and reducing marginal zone B cells. This impacts humoral immune responses, highlighting CARMA1
Area of Science:
- Immunology
- Molecular Biology
Background:
- NF-kappaB activation via B cell receptor (BCR) ligation is vital for B cell functions.
- CARMA1 is an adaptor molecule essential for BCR-induced NF-kappaB activation and B cell proliferation.
- CARMA1-deficient B cells exhibit defective proliferation upon BCR stimulation, impacting humoral responses.
Purpose of the Study:
- To investigate the mechanisms underlying the defective CD40-induced proliferation in CARMA1-deficient B cells.
- To elucidate the role of CARMA1 in CD40 signaling pathways and B cell maturation.
Main Methods:
- Analysis of signaling cascades activated by CD40 stimulation in CARMA1-deficient B cells.
- Assessment of cell-cycle progression in CARMA1-deficient B cells.
- Quantification of marginal zone (MZ) B cell populations in CARMA1-deficient mice.
Main Results:
- CD40-induced signaling cascades are largely unaffected in CARMA1-deficient B cells.
- CARMA1-deficient B cells display defective cell-cycle progression.
- There is a significant reduction in the number of marginal zone (MZ) B cells in CARMA1-deficient mice.
Conclusions:
- Defective proliferation in CARMA1-deficient B cells stems from impaired cell-cycle progression and diminished MZ B cell numbers.
- Impaired BCR signaling in CARMA1-deficient mice leads to defective MZ B cell maturation.
- This defective MZ B cell maturation contributes to the impaired proliferation observed upon CD40 stimulation, affecting overall humoral immunity.
Abstract:
NF-kappaB activation through B cell receptor (BCR) ligation is critical for B cell development, survival and antigen-mediated activation of B cells. CARD domain and MAGUK-domain containing protein-1 (CARMA1), recently identified adaptor molecule, has been shown to play an essential role in BCR-induced NF-kappaB activation. CARMA1-deficient B cells fail to proliferate upon BCR stimulation, leading to defective humoral responses. Surprisingly, CARMA1-deficient B cells are also defective in CD40-induced proliferation. The mechanisms responsible for CD40-induced proliferation defect have not yet been characterized. In this study, we show that signaling cascades activated by CD40 stimulation are largely unaffected in CARMA1-deficient B cells. Instead, we have found that the defective proliferation of CARMA1-deficient B cells is due to two events. First, CARMA1-deficient B cells show defective cell-cycle progression. Secondly, the numbers of marginal zone (MZ) B cells, which are the main responders upon CD40 stimulation, are greatly diminished in CARMA1-deficient mice. Since B cell maturation requires basal signaling through BCR and NF-kappaB activation, we propose that impaired BCR signaling in CARMA1-deficient mice leads to defective maturation of MZ B cell population, which in turn, contributes to impaired proliferation upon CD40 stimulation.
Related Concept Videos
T Cell Activation and Clonal Selection
Naive T cells that have not yet encountered an antigen express two primary CD...
Regulation of Hematopoietic Stem Cells
B Cell Activation and Differentiation
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
Cells of the Adaptive Immune Response
Lineage Commitment
Differentiation of Common Myeloid Progenitor Cells

